BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 22288669)

  • 1. A new sublingual formulation of zolpidem for the treatment of sleep-onset insomnia.
    Staner L; Danjou P; Luthringer R
    Expert Rev Neurother; 2012 Feb; 12(2):141-53. PubMed ID: 22288669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sublingual zolpidem in early onset of sleep compared to oral zolpidem: polysomnographic study in patients with primary insomnia.
    Staner C; Joly F; Jacquot N; Vlasova ID; Nehlin M; Lundqvist T; Edenius C; Staner L
    Curr Med Res Opin; 2010 Jun; 26(6):1423-31. PubMed ID: 20397964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublingual zolpidem is more effective than oral zolpidem in initiating early onset of sleep in the post-nap model of transient insomnia: a polysomnographic study.
    Staner L; Eriksson M; Cornette F; Santoro F; Muscat N; Luthinger R; Roth T
    Sleep Med; 2009 Jun; 10(6):616-20. PubMed ID: 18996742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sublingual zolpidem (Edluar™; Sublinox™).
    Yang LP; Deeks ED
    CNS Drugs; 2012 Nov; 26(11):1003-10. PubMed ID: 23034583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T; Soubrane C; Titeux L; Walsh JK;
    Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB; Roth T; Vogel GW; Walsh JK
    J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eight weeks of non-nightly use of zolpidem for primary insomnia.
    Walsh JK; Roth T; Randazzo A; Erman M; Jamieson A; Scharf M; Schweitzer PK; Ware JC
    Sleep; 2000 Dec; 23(8):1087-96. PubMed ID: 11145323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zolpidem extended-release: a single insomnia treatment option for sleep induction and sleep maintenance symptoms.
    Barkin RL
    Am J Ther; 2007; 14(3):299-305. PubMed ID: 17515707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
    Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
    J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zolpidem for insomnia.
    Greenblatt DJ; Roth T
    Expert Opin Pharmacother; 2012 Apr; 13(6):879-93. PubMed ID: 22424586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of zolpidem extended release in elderly primary insomnia patients.
    Walsh JK; Soubrane C; Roth T
    Am J Geriatr Psychiatry; 2008 Jan; 16(1):44-57. PubMed ID: 18165461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "As needed" pharmacotherapy combined with stimulus control treatment in chronic insomnia--assessment of a novel intervention strategy in a primary care setting.
    Hajak G; Bandelow B; Zulley J; Pittrow D
    Ann Clin Psychiatry; 2002 Mar; 14(1):1-7. PubMed ID: 12046635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zolpidem is not superior to temazepam with respect to rebound insomnia: a controlled study.
    Voshaar RC; van Balkom AJ; Zitman FG
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):301-6. PubMed ID: 15163440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
    Dorsey CM; Lee KA; Scharf MB
    Clin Ther; 2004 Oct; 26(10):1578-86. PubMed ID: 15598474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insomnia: zolpidem extended-release for the treatment of sleep induction and sleep maintenance symptoms.
    Doghramji PP
    MedGenMed; 2007 Jan; 9(1):11. PubMed ID: 17435620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender influences on efficacy and safety of sublingual zolpidem tartrate for middle-of-the-night awakening in insomnia.
    Roth T; Steinberg F; Singh NN; Moline M
    Hum Psychopharmacol; 2014 Jan; 29(1):25-30. PubMed ID: 24424704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conventional and power spectrum analysis of the effects of zolpidem on sleep EEG in patients with chronic primary insomnia.
    Monti JM; Alvariño F; Monti D
    Sleep; 2000 Dec; 23(8):1075-84. PubMed ID: 11145322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States.
    Jhaveri M; Seal B; Pollack M; Wertz D
    Curr Med Res Opin; 2007 Jun; 23(6):1431-43. PubMed ID: 17559740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison.
    Jacobs GD; Pace-Schott EF; Stickgold R; Otto MW
    Arch Intern Med; 2004 Sep; 164(17):1888-96. PubMed ID: 15451764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypnotic dependence: zolpidem and zopiclone too.
    Prescrire Int; 2001 Feb; 10(51):15. PubMed ID: 11503851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.